Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
Ferrous fumarate Ph.Eur.
Thornton & Ross Limited
B03AA; B03AA02
Ferrous fumarate Ph.Eur.
140 mg/5ml
Oral suspension
Product not subject to medical prescription
Iron bivalent, oral preparations; ferrous fumarate
Marketed
1988-07-25
PACKAGE LEAFLET: INFORMATION FOR THE USER GALFER 140MG/5ML ORAL SUSPENSION ferrous fumarate READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to take Galfer Oral Suspension carefully to get the best results from it. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need any more information or advice. • You must contact your doctor if your symptoms worsen or do not improve. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Galfer Oral Suspension is and what it is used for 2. Before you take Galfer Oral Suspension 3. How to take Galfer Oral Suspension 4. Possible side effects 5. How to store Galfer Oral Suspension 6. Further information 1. WHAT GALFER ORAL SUSPENSION IS AND WHAT IT IS USED FOR Galfer Oral Suspension contains ferrous fumarate which is used to replace low levels of iron in the blood. It is used to treat and prevent anaemia caused by iron deficiency. This product should only be used for the treatment of iron deficiency anaemia diagnosed by laboratory testing under the supervision of a doctor. 2. BEFORE YOU TAKE GALFER ORAL SUSPENSION DO NOT TAKE THE MEDICINE IF YOU OR YOUR CHILD HAVE…. • An ALLERGY to any of the ingredients listed in section 6. • Other PROBLEMS WITH IRON IN THE BLOOD (including conditions that lead to iron building up in soft tissues, or problems with red blood cells). • A STOMACH ULCER or other STOMACH OR BOWEL PROBLEM. • Had REPEATED BLOOD TRANSFUSIONS in the past. • ANAEMIA NOT RELATED TO LOW LEVELS OF IRON. • Are currently HAVING IRON INJECTIONS . • Or are taking dimercaprol for metal poisoning. TAKE SPECIAL CARE WITH GALFER ORAL SUSPENSION IF YOU OR YOUR CHILD HAVE…. • A family history of conditions that lead to iron building up or iron overload in the blood. • A history of stomach ulcers. • H Preberite celoten dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Galfer 140 mg/5ml Oral Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: Each 5ml contains 140mg Ferrous Fumarate equivalent to 45 mg elemental iron. Excipients: each 5ml contains 6.250mg Nipasept sodium (containing sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215), sodium propyl parahydroxybenzoate (E217) and 5.0g of Liquid Maltitol E965)). For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension (oral liquid) A brown liquid suspension with a chocolate/mint odour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This product is indicated for the prevention and treatment of iron deficiency states. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. a) Prevention of iron deficiency: ADULTS, THE ELDERLY AND CHILDREN OVER 12 YEARS: Two 5ml spoonfuls (10ml) taken once daily. INFANTS AND YOUNG CHILDREN (UNDER 12 YEARS): 1-2 mg elemental Iron per Kg body weight per day. Maximum dose not to exceed 15mg Iron per day. Dosage of Galfer Syrup to be determined by the physician. b) Treatment of iron deficiency: ADULTS, THE ELDERLY AND CHILDREN OVER 12 YEARS: Two 5ml spoonfuls (10ml) taken twice daily. INFANTS LESS THAN ONE MONTH OLD: 2-4 mg elemental iron per Kg body weight per day. To be taken in divided doses. Maximum dose not to exceed 15 mg Iron per day. Dosage of Galfer Syrup to be determined by the physician. INFANTS OVER ONE MONTH OLD AND CHILDREN UNDER 12 YEARS: 3-6 mg elemental Iron per Kg body weight per day. To be taken in divided doses. Dosage of Galfer Syrup to be determined by the physician. Administration to infants and children should take place under medical supervision. Medical advice should be sought if symptoms do not improve after four weeks of use of this product as these symptoms may reflect an underlying disease process. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ Preberite celoten dokument